長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【7775】大研医器

【7775】大研医器
医療機器メーカー。『真空吸引器』『加圧式医薬品注入器』など。
類似企業：
【業界1位】 テルモ
【売上同水準】 北里 シンシア


東証プライム
精密
＞
医器
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2027.03 2026/07/31 Q1予 10,500 → 0.0% 0.0% 840 → 0.0% 0.0% 825 → 0.0% 0.0% 590 → 0.0% 0.0%
2027.03 2026/05/15 当初予 10,500 - - - 840 - - - 825 - - - 590 - - -
2026.03 2026/05/15 実 10,290 ↑ +0.9% -2.0% 1,277 ↑ +2.2% +26.4% 1,274 ↑ +1.9% +27.4% 922 ↑ +4.8% +31.7%
2026.03 2026/01/30 Q3予 10,200 ↓ -2.9% -2.9% 1,250 ↑ +23.8% +23.8% 1,250 ↑ +25.0% +25.0% 880 ↑ +25.7% +25.7%
2026.03 2025/10/31 Q2予 10,500 → 0.0% 0.0% 1,010 → 0.0% 0.0% 1,000 → 0.0% 0.0% 700 → 0.0% 0.0%
2026.03 2025/07/31 Q1予 10,500 → 0.0% 0.0% 1,010 → 0.0% 0.0% 1,000 → 0.0% 0.0% 700 → 0.0% 0.0%
2026.03 2025/05/15 当初予 10,500 - - - 1,010 - - - 1,000 - - - 700 - - -
2025.03 2025/05/15 実 9,951 ↓ -1.5% -1.5% 1,512 ↑ +0.8% +0.8% 1,510 ↑ +0.7% +0.7% 1,097 ↑ +6.5% +6.5%
2025.03 2025/01/31 Q3予 10,100 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2025.03 2024/10/31 Q2予 10,100 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2025.03 2024/07/31 Q1予 10,100 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2025.03 2024/05/15 当初予 10,100 - - - 1,500 - - - 1,500 - - - 1,030 - - -
2024.03 2024/05/15 実 9,750 ↑ +0.5% +1.6% 1,442 ↑ +3.0% +10.9% 1,450 ↑ +3.6% +11.5% 988 ↑ +0.8% +9.8%
2024.03 2024/01/31 Q3予 9,700 ↑ +1.0% +1.0% 1,400 ↑ +7.7% +7.7% 1,400 ↑ +7.7% +7.7% 980 ↑ +8.9% +8.9%
2024.03 2023/10/31 Q2予 9,600 → 0.0% 0.0% 1,300 → 0.0% 0.0% 1,300 → 0.0% 0.0% 900 → 0.0% 0.0%
2024.03 2023/07/31 Q1予 9,600 → 0.0% 0.0% 1,300 → 0.0% 0.0% 1,300 → 0.0% 0.0% 900 → 0.0% 0.0%
2024.03 2023/05/15 当初予 9,600 - - - 1,300 - - - 1,300 - - - 900 - - -
2023.03 2023/05/15 実 9,137 ↑ +0.1% +4.4% 1,054 ↑ +0.4% -12.2% 1,053 ↑ +0.3% -12.3% 712 ↑ +0.3% -15.2%
2023.03 2023/04/28 修正予 9,130 ↑ +1.4% +4.3% 1,050 ↓ -12.5% -12.5% 1,050 ↓ -12.5% -12.5% 710 ↓ -15.5% -15.5%
2023.03 2023/01/31 Q3予 9,000 → 0.0% +2.9% 1,200 → 0.0% 0.0% 1,200 → 0.0% 0.0% 840 → 0.0% 0.0%
2023.03 2022/10/31 Q2予 9,000 ↑ +2.9% +2.9% 1,200 → 0.0% 0.0% 1,200 → 0.0% 0.0% 840 → 0.0% 0.0%
2023.03 2022/07/29 Q1予 8,750 → 0.0% 0.0% 1,200 → 0.0% 0.0% 1,200 → 0.0% 0.0% 840 → 0.0% 0.0%
2023.03 2022/05/13 当初予 8,750 - - - 1,200 - - - 1,200 - - - 840 - - -
2022.03 2022/05/13 実 8,540 ↑ +1.7% -5.1% 1,150 ↑ +4.5% -4.2% 1,152 ↑ +4.7% -4.0% 831 ↑ +7.9% -1.1%
2022.03 2022/01/31 Q3予 8,400 → 0.0% -6.7% 1,100 → 0.0% -8.3% 1,100 → 0.0% -8.3% 770 → 0.0% -8.3%
2022.03 2021/10/29 Q2予 8,400 ↓ -6.7% -6.7% 1,100 ↓ -8.3% -8.3% 1,100 ↓ -8.3% -8.3% 770 ↓ -8.3% -8.3%
2022.03 2021/07/30 Q1予 9,000 → 0.0% 0.0% 1,200 → 0.0% 0.0% 1,200 → 0.0% 0.0% 840 → 0.0% 0.0%
2022.03 2021/05/14 当初予 9,000 - - - 1,200 - - - 1,200 - - - 840 - - -
2021.03 2021/05/14 実 7,861 ↓ -1.7% -6.4% 921 ↓ -4.1% -20.6% 957 ↓ -4.3% -20.3% 675 ↓ -4.9% -21.5%
2021.03 2021/01/29 Q3予 8,000 ↓ -4.8% -4.8% 960 ↓ -17.2% -17.2% 1,000 ↓ -16.7% -16.7% 710 ↓ -17.4% -17.4%
2021.03 2020/10/30 Q2予 8,400 → 0.0% 0.0% 1,160 → 0.0% 0.0% 1,200 → 0.0% 0.0% 860 → 0.0% 0.0%
2021.03 2020/07/31 当初予 8,400 - - - 1,160 - - - 1,200 - - - 860 - - -
2020.03 2020/05/15 実 8,523 ↑ +0.3% +0.3% 1,194 ↓ -2.9% -6.7% 1,210 ↓ -3.2% -6.9% 859 ↓ -0.1% -1.3%
2020.03 2020/01/31 Q3予 8,500 → 0.0% 0.0% 1,230 ↓ -3.9% -3.9% 1,250 ↓ -3.8% -3.8% 860 ↓ -1.1% -1.1%
2020.03 2019/10/31 Q2予 8,500 → 0.0% 0.0% 1,280 → 0.0% 0.0% 1,300 → 0.0% 0.0% 870 → 0.0% 0.0%
2020.03 2019/07/31 Q1予 8,500 → 0.0% 0.0% 1,280 → 0.0% 0.0% 1,300 → 0.0% 0.0% 870 → 0.0% 0.0%
2020.03 2019/05/15 当初予 8,500 - - - 1,280 - - - 1,300 - - - 870 - - -
2019.03 2019/05/15 実 8,406 ↑ +0.1% -6.6% 1,249 ↓ -0.1% -21.9% 1,245 ↓ -0.4% -22.2% 851 ↑ +0.1% -23.3%
2019.03 2019/01/31 Q3予 8,400 ↓ -2.3% -6.7% 1,250 ↓ -10.7% -21.9% 1,250 ↓ -10.7% -21.9% 850 ↓ -12.4% -23.4%
2019.03 2018/10/31 Q2予 8,600 ↓ -4.4% -4.4% 1,400 ↓ -12.5% -12.5% 1,400 ↓ -12.5% -12.5% 970 ↓ -12.6% -12.6%
2019.03 2018/07/31 Q1予 9,000 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,110 → 0.0% 0.0%
2019.03 2018/05/15 当初予 9,000 - - - 1,600 - - - 1,600 - - - 1,110 - - -
2018.03 2018/05/15 実 8,585 ↓ -0.2% -0.2% 1,505 ↓ -2.9% -2.9% 1,504 ↓ -3.0% -3.0% 1,012 ↓ -1.7% -1.7%
2018.03 2018/01/31 Q3予 8,600 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2018.03 2017/10/31 Q2予 8,600 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2018.03 2017/07/31 Q1予 8,600 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,030 → 0.0% 0.0%
2018.03 2017/05/15 当初予 8,600 - - - 1,550 - - - 1,550 - - - 1,030 - - -
2017.03 2017/05/15 実 8,399 ↓ -1.8% -1.8% 1,711 ↓ -1.7% -1.7% 1,714 ↓ -2.1% -2.1% 1,246 ↑ +3.8% +3.8%
2017.03 2017/01/31 Q3予 8,550 → 0.0% 0.0% 1,740 → 0.0% 0.0% 1,750 → 0.0% 0.0% 1,200 → 0.0% 0.0%
2017.03 2016/10/28 Q2予 8,550 → 0.0% 0.0% 1,740 → 0.0% 0.0% 1,750 → 0.0% 0.0% 1,200 → 0.0% 0.0%
2017.03 2016/07/29 Q1予 8,550 → 0.0% 0.0% 1,740 → 0.0% 0.0% 1,750 → 0.0% 0.0% 1,200 → 0.0% 0.0%
2017.03 2016/05/13 当初予 8,550 - - - 1,740 - - - 1,750 - - - 1,200 - - -
2016.03 2016/05/13 実 8,261 ↑ +0.1% -3.7% 1,695 ↑ +3.4% -1.0% 1,704 ↑ +3.3% +0.2% 1,153 ↑ +0.3% +2.7%
2016.03 2016/01/29 Q3予 8,250 ↓ -3.8% -3.8% 1,640 ↓ -4.2% -4.2% 1,650 ↓ -2.9% -2.9% 1,150 ↑ +2.4% +2.4%
2016.03 2015/10/30 Q2予 8,580 → 0.0% 0.0% 1,712 → 0.0% 0.0% 1,700 → 0.0% 0.0% 1,123 → 0.0% 0.0%
2016.03 2015/07/31 Q1予 8,580 → 0.0% 0.0% 1,712 → 0.0% 0.0% 1,700 → 0.0% 0.0% 1,123 → 0.0% 0.0%
2016.03 2015/05/15 当初予 8,580 - - - 1,712 - - - 1,700 - - - 1,123 - - -
2015.03 2015/05/15 実 8,033 ↓ -1.1% -1.1% 1,621 ↑ +4.2% +4.2% 1,623 ↑ +4.7% +4.7% 1,097 ↑ +11.0% +11.0%
2015.03 2015/01/30 Q3予 8,120 → 0.0% 0.0% 1,555 → 0.0% 0.0% 1,550 → 0.0% 0.0% 988 → 0.0% 0.0%
2015.03 2014/10/31 Q2予 8,120 → 0.0% 0.0% 1,555 → 0.0% 0.0% 1,550 → 0.0% 0.0% 988 → 0.0% 0.0%
2015.03 2014/07/31 Q1予 8,120 → 0.0% 0.0% 1,555 → 0.0% 0.0% 1,550 → 0.0% 0.0% 988 → 0.0% 0.0%
2015.03 2014/05/14 当初予 8,120 - - - 1,555 - - - 1,550 - - - 988 - - -
2014.03 2014/05/14 実 7,635 ↑ +1.1% +1.1% 1,389 ↓ -0.4% -0.4% 1,401 ↑ +0.1% +0.1% 881 ↑ +0.1% +0.1%
2014.03 2014/01/31 当初予 7,550 - - - 1,395 - - - 1,400 - - - 880 - - -
シェア ツイート
ページトップへ戻る